Page 1 of Clinical Trials for Genetic TdT-mediated dUTP nick end labeling assay, 10 Total Matches
- 1Active, not recruitingLast Updated: May 17, 2012Condition(s): Breast Cancer
- 2RecruitingLast Updated: October 26, 2011Condition(s): Recurrent Melanoma; Stage IIIC Melanoma; Stage IV Melanoma
- 3RecruitingLast Updated: June 9, 2009Condition(s): Breast Cancer
- 4RecruitingLast Updated: August 11, 2009Condition(s): Head and Neck Cancer
- 5CompletedLast Updated: May 19, 2010Condition(s): Breast Cancer
- 6RecruitingLast Updated: February 6, 2009Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
- 7Active, not recruitingLast Updated: October 17, 2011Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
- 8RecruitingLast Updated: February 2, 2010Condition(s): Esophageal Cancer
- 9Active, not recruitingLast Updated: August 16, 2011Condition(s): Head and Neck Cancer
- 10CompletedLast Updated: October 11, 2010Condition(s): Malignant Mesothelioma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Genetic+TdT-mediated+dUTP+nick+end+labeling+assay
